| |||||||
Type Mutant Strain; Targeted Mutation; Additional information on Genetically Engineered Mutant Mice. Species laboratory mouse Generation F?+4p (08-JAN-04) Donating Investigator Dean Sheppard, UCSF Description
Mice that are homozygous for the Itgb5tm1Des targeted mutation are viable, fertile, normal in size, and do not display any gross physical or behavioral abnormalities. No Itgb5 gene product (mRNA or protein) is detected. Homozygotes display defects in VEGF-mediated vascular permeability. Cultured keratinocytes derived from homozygous mutant animals display impaired adhesion and migration on vitronectin-coated surfaces.Development
A targeting vector containing neomycin resistance and herpes simplex virus thymidine kinase genes was used to disrupt a region of the Itgb5 gene corresponding to human amino acids 114-230. The construct was electroporated into 129S4/SvJae-derived RF8 embryonic stem (ES) cells. Correctly targeted ES cells were injected into C57BL/6 blastocysts. The resulting chimeric animals were mated to an unspecified strain of 129 mice.
View Mammalian Phenotype Terms
Mammalian Phenotype Terms
assigned by genotype
The following phenotype information may relate to a genetic background differing from this JAX® Mice strain.
Itgb5tm1Des/Itgb5tm1Des
involves: 129S4/SvJae * C57BL/6J
- skin/coat/nails phenotype
- abnormal keratinocyte differentiation (MGI Ref ID J:59991)
- cultured keratinocytes derived from homozygous animals display impaired adhesion and migration on vitronectin-coated surfaces
- normal phenotype
- no abnormal phenotype detected (MGI Ref ID J:59991)
- homozygotes are viable, fertile, normal in size and do not display any gross physical or behavioral abnormalities
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:Itgb5tm1Des related
Cancer Research
Growth Factors/Receptors/Cytokines (Osteoporosis)
Cardiovascular Research
Vascular Defects
Cell Biology Research
Defects in Cell Adhesion Molecules
Developmental Biology Research
Defects in Cell Adhesion Molecules
Endocrine Deficiency Research
Bone/Bone Marrow Defects
Vasculature Defects
Neurobiology Research
Research Tools
Cell Biology Research
Immunology and Inflammation Research
Internal/Organ Research
Virology Research
Adenovirus Receptor
| Allele Symbol | Itgb5tm1Des | ||
|---|---|---|---|
| Allele Name | targeted mutation 1, Dean Sheppard | ||
| Allele Type | Targeted (knock-out) | ||
| Common Name(s) | beta5-; | ||
| Mutation Made By | Xiaozhu Huang, UCSF | ||
| Strain of Origin | 129S4/SvJae | ||
| ES Cell Line Name | RF8 | ||
| ES Cell Line Strain | 129S4/SvJae | ||
| Gene Symbol and Name | Itgb5, integrin beta 5 | ||
| Chromosome | 16 | ||
| Gene Common Name(s) | AA475909; AI874634; EST AA475909; ESTM23; FLJ26658; [b]-5; [b]5; [b]5A; [b]5B; beta-5; beta5; expressed sequence AI874634; expressed sequence tag mouse EST 23; | ||
| Molecular Note | Insertion of a neomycin resistance cassette replaced part of an exon of the gene that corresponds to amino acids 114 to 230 in the reported human sequence, and an adjacent intron. Northern analysis using a murine cDNA probe did not detect transcript in cultured keratinocytes from homozygous mutant mice. Immunoprecipitation studies using antiserum raised against the cytoplasmic domain of human did not detect protein in lysates of cultured keratinocytes from homozygous mutant mice. [MGI Ref ID J:59991] | ||
This strain will not have a genotyping protocol or one is not currently available.
Helpful Links
Optimizing PCR Protocols
Huang X; Griffiths M; Wu J; Farese RV Jr; Sheppard D. 2000. Normal development, wound healing, and adenovirus susceptibility in beta5-deficient mice. Mol Cell Biol 20(3):755-9. [PubMed: 10629031] [MGI Ref ID J:59991]
Reynolds LE; Wyder L; Lively JC; Taverna D; Robinson SD; Huang X; Sheppard D; Hynes RO; Hodivala-Dilke KM. 2002. Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. Nat Med 8(1):27-34. [PubMed: 11786903] [MGI Ref ID J:73752]
Itgb5tm1Des relatedBelvindrah R; Hankel S; Walker J; Patton BL; Muller U. 2007. Beta1 integrins control the formation of cell chains in the adult rostral migratory stream. J Neurosci 27(10):2704-17. [PubMed: 17344408] [MGI Ref ID J:120076]
Lane NE; Yao W; Nakamura MC; Humphrey MB; Kimmel D; Huang X; Sheppard D; Ross FP; Teitelbaum SL. 2005. Mice lacking the integrin beta5 subunit have accelerated osteoclast maturation and increased activity in the estrogen-deficient state. J Bone Miner Res 20(1):58-66. [PubMed: 15619670] [MGI Ref ID J:102247]
Nandrot EF; Anand M; Almeida D; Atabai K; Sheppard D; Finnemann SC. 2007. Essential role for MFG-E8 as ligand for {alpha}vbeta5 integrin in diurnal retinal phagocytosis. Proc Natl Acad Sci U S A 104(29):12005-10. [PubMed: 17620600] [MGI Ref ID J:123148]
Nandrot EF; Anand M; Sircar M; Finnemann SC. 2006. Novel role for alphavbeta5-integrin in retinal adhesion and its diurnal peak. Am J Physiol Cell Physiol 290(4):C1256-62. [PubMed: 16338970] [MGI Ref ID J:107356]
Nandrot EF; Kim Y; Brodie SE; Huang X; Sheppard D; Finnemann SC. 2004. Loss of synchronized retinal phagocytosis and age-related blindness in mice lacking alphavbeta5 integrin. J Exp Med 200(12):1539-45. [PubMed: 15596525] [MGI Ref ID J:95338]
Reynolds LE; Wyder L; Lively JC; Taverna D; Robinson SD; Huang X; Sheppard D; Hynes RO; Hodivala-Dilke KM. 2002. Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. Nat Med 8(1):27-34. [PubMed: 11786903] [MGI Ref ID J:73752]
Schulz O; Pennington DJ; Hodivala-Dilke K; Febbraio M; Reis e Sousa C. 2002. CD36 or alphavbeta3 and alphavbeta5 integrins are not essential for MHC class I cross-presentation of cell-associated antigen by CD8 alpha+ murine dendritic cells. J Immunol 168(12):6057-65. [PubMed: 12055214] [MGI Ref ID J:123797]
Su G; Hodnett M; Wu N; Atakilit A; Kosinski C; Godzich M; Huang XZ; Kim JK; Frank JA; Matthay MA; Sheppard D; Pittet JF. 2007. Integrin alphavbeta5 regulates lung vascular permeability and pulmonary endothelial barrier function. Am J Respir Cell Mol Biol 36(3):377-86. [PubMed: 17079779] [MGI Ref ID J:132113]
Taverna D; Crowley D; Connolly M; Bronson RT; Hynes RO. 2005. A direct test of potential roles for beta3 and beta5 integrins in growth and metastasis of murine mammary carcinomas. Cancer Res 65(22):10324-9. [PubMed: 16288021] [MGI Ref ID J:103405]
Colony Maintenance
Breeding & Husbandry This strain originated from a chimeric mouse on a B6;129S4 background which was mated to an unspecified 129 strain once before being made homozygous.
| Pricing for USA, Canada and Mexico shipping destinations |
|
*Price(s) in US dollars ($)
Weeks of Age Price* Gender Cryorecovery Fee $1900.00 Cryopreserved Embryos Fee $1600.00
| Pricing for International shipping destinations |
|
*Price(s) in US dollars ($)
Weeks of Age Price* Gender Cryorecovery Fee $2470.00 Cryopreserved Embryos Fee $2080.00
| Standard Supply | Repository-Cryopreserved. Must Be Recovered. Please refer to pricing and supply notes for further information. |
|---|---|
| Supply Notes |
|
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. THE LABORATORY EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of MICE, products or services, The Jackson Laboratory will, at its option, provide credit or replacement for the MICE or product received or the services provided.
In no event shall The Jackson Laboratory, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, products or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of The Jackson Laboratory, its agents or employees. In purchasing or receiving MICE, products or services from The Jackson Laboratory, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges The Jackson Laboratory from all such causes of action or damages, and further agrees to defend and indemnify The Jackson Laboratory from any costs or damages arising out of any third party claims.
MICE and biological materials are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to The Jackson Laboratory’s MICE, products and services. In addition, special terms and conditions of sale of certain MICE, products and services may be set forth separately in The Jackson Laboratory web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, products and services by The Jackson Laboratory, and by its licensees and distributors.
Acceptance of delivery of MICE, products or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on The Jackson Laboratory, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, products services by The Jackson Laboratory.